Evidence map›Paper›PMID 41963625›Full record

ArticleNPJ precision oncology2026

Deepath-SCC: a deep learning model for accurate tissue origin identification in squamous cell carcinoma.

Siwei Lu, Yue Pang, Huer Wen, Linyi Hu, Xiaoli Zhou, Xiao Yang, Xiaowei Qi, Cong Liu, Jing Liu, Peng Qi and 4 more

Abstract read
In one paragraph

Article in NPJ precision oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Siwei Lu *Department of Pathology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Yue Pang *Department of Pathology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Huer Wen *Canhelp Genomics Research Center, Canhelp Genomics Co. Ltd., Hangzhou, China.
Linyi Hu *Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Xiaoli ZhouDepartment of Pathology, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, China.
Xiao YangCanhelp Genomics Research Center, Canhelp Genomics Co. Ltd., Hangzhou, China.
Xiaowei QiDepartment of Pathology, Affiliated Hospital of Jiangnan University, Wuxi, China.
Cong LiuCenter of Medical Physics, Nanjing Medical University, Changzhou, China.
Jing LiuDepartment of Pathology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Peng QiDepartment of Pathology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Shenglin HuangDepartment of Pathology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Qinghua XuCanhelp Genomics Research Center, Canhelp Genomics Co. Ltd., Hangzhou, China.
Yifeng SunDepartment of Pathology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, China. yifeng.sun@canhelpgenomics.com.
Qifeng WangDepartment of Pathology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, China. wangqifeng19821982@126.com.

Funding

National Natural Science Foundation of China 82272626Natural Science Foundation of Zhejiang Province LY21H160054
6 · The paper itself

Abstract

Squamous cell carcinoma (SCC) is a common malignancy that arises in diverse organs and often exhibits overlapping histological and immunophenotypic features, making accurate determination of the tissue of origin challenging with conventional pathology. To address this, we developed Deepath-SCC, a deep learning model for pan-SCC tissue origin identification directly from hematoxylin and eosin-stained whole-slide images. A retrospective cohort of 4217 whole slide images across nasopharyngeal, head and neck/esophageal, lung, cervical, and urothelial carcinomas was assembled for model training and validation. In the internal test set, Deepath-SCC reached accuracy of 91.2%, with micro area under the receiver operating characteristic curves (AUROC) reaching 0.986 (95% CI: 0.984-0.989). Among high-confidence predictions (similarity score ≥0.7914), the overall accuracy increased to 96.2%, including 96.4% for primary SCCs and 94.4% for metastatic SCCs. In an external test set, Deepath-SCC achieved an accuracy of 86.1% with an AUROC of 0.972 (95% CI: 0.961-0.982). These results provide initial evidence supporting the feasibility of deep learning-based digital pathology for tissue-of-origin prediction in pan-SCC. Deepath-SCC represents an efficient, and cost-effective computational approach that may complement existing diagnostic workflows, particularly in challenging or resource-limited clinical settings.

Identifiers

PMID41963625
PMCPMC13254084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.